320 related articles for article (PubMed ID: 11991962)
1. Characterization of CHAT and Cox type 1 live-attenuated poliovirus vaccine strains.
Martín J; Minor PD
J Virol; 2002 Jun; 76(11):5339-49. PubMed ID: 11991962
[TBL] [Abstract][Full Text] [Related]
2. Sabin type 2 polioviruses with intertypic vaccine/vaccine recombinant genomes.
Georgopoulou A; Markoulatos P
Eur J Clin Microbiol Infect Dis; 2001 Nov; 20(11):792-9. PubMed ID: 11783695
[TBL] [Abstract][Full Text] [Related]
3. Evolution of the Sabin type 1 poliovirus in humans: characterization of strains isolated from patients with vaccine-associated paralytic poliomyelitis.
Georgescu MM; Balanant J; Macadam A; Otelea D; Combiescu M; Combiescu AA; Crainic R; Delpeyroux F
J Virol; 1997 Oct; 71(10):7758-68. PubMed ID: 9311861
[TBL] [Abstract][Full Text] [Related]
4. Polioviruses with natural recombinant genomes isolated from vaccine-associated paralytic poliomyelitis.
Furione M; Guillot S; Otelea D; Balanant J; Candrea A; Crainic R
Virology; 1993 Sep; 196(1):199-208. PubMed ID: 8102826
[TBL] [Abstract][Full Text] [Related]
5. Genetic basis of the neurovirulence of type 1 polioviruses isolated from vaccine-associated paralytic patients.
Li J; Zhang LB; Yoneyama T; Yoshida H; Shimizu H; Yoshii K; Hara M; Nomura T; Yoshikura H; Miyamura T; Hagiwara A
Arch Virol; 1996; 141(6):1047-54. PubMed ID: 8712922
[TBL] [Abstract][Full Text] [Related]
6. A Cluster of Paralytic Poliomyelitis Cases Due to Transmission of Slightly Diverged Sabin 2 Vaccine Poliovirus.
Korotkova EA; Gmyl AP; Yakovenko ML; Ivanova OE; Eremeeva TP; Kozlovskaya LI; Shakaryan AK; Lipskaya GY; Parshina IL; Loginovskikh NV; Morozova NS; Agol VI
J Virol; 2016 Jul; 90(13):5978-88. PubMed ID: 27099315
[TBL] [Abstract][Full Text] [Related]
7. Rational design of genetically stable, live-attenuated poliovirus vaccines of all three serotypes: relevance to poliomyelitis eradication.
Macadam AJ; Ferguson G; Stone DM; Meredith J; Knowlson S; Auda G; Almond JW; Minor PD
J Virol; 2006 Sep; 80(17):8653-63. PubMed ID: 16912313
[TBL] [Abstract][Full Text] [Related]
8. Point mutations involved in the attenuation/neurovirulence alternation in type 1 and 2 oral polio vaccine strains detected by site-specific polymerase chain reaction.
Guillot S; Otelea D; Delpeyroux F; Crainic R
Vaccine; 1994 May; 12(6):503-7. PubMed ID: 8036823
[TBL] [Abstract][Full Text] [Related]
9. Nucleotide variation in Sabin type 2 poliovirus from an immunodeficient patient with poliomyelitis.
Buttinelli G; Donati V; Fiore S; Marturano J; Plebani A; Balestri P; Soresina AR; Vivarelli R; Delpeyroux F; Martin J; Fiore L
J Gen Virol; 2003 May; 84(Pt 5):1215-1221. PubMed ID: 12692287
[TBL] [Abstract][Full Text] [Related]
10. Brunenders: a partially attenuated historic poliovirus type I vaccine strain.
Sanders BP; Liu Y; Brandjes A; van Hoek V; de Los Rios Oakes I; Lewis J; Wimmer E; Custers JHHV; Schuitemaker H; Cello J; Edo-Matas D
J Gen Virol; 2015 Sep; 96(9):2614-2622. PubMed ID: 26018960
[TBL] [Abstract][Full Text] [Related]
11. Genomic modifications in Sabin vaccine strains isolated from vaccination-associated cases, healthy contacts and healthy vaccinees.
Friedrich F
Acta Virol; 1996 Jun; 40(3):157-70. PubMed ID: 8891097
[TBL] [Abstract][Full Text] [Related]
12. Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria.
Famulare M; Chang S; Iber J; Zhao K; Adeniji JA; Bukbuk D; Baba M; Behrend M; Burns CC; Oberste MS
J Virol; 2016 Jan; 90(1):317-31. PubMed ID: 26468545
[TBL] [Abstract][Full Text] [Related]
13. The vaccine origin of the 1968 epidemic of type 3 poliomyelitis in Poland.
Martín J; Ferguson GL; Wood DJ; Minor PD
Virology; 2000 Dec; 278(1):42-9. PubMed ID: 11112479
[TBL] [Abstract][Full Text] [Related]
14. Nucleotide variation in Sabin type 3 poliovirus from an Albanian infant with agammaglobulinemia and vaccine associated poliomyelitis.
Foiadelli T; Savasta S; Battistone A; Kota M; Passera C; Fiore S; Bino S; Amato C; Lozza A; Marseglia GL; Fiore L
BMC Infect Dis; 2016 Jun; 16():277. PubMed ID: 27287521
[TBL] [Abstract][Full Text] [Related]
15. Natural genetic exchanges between vaccine and wild poliovirus strains in humans.
Guillot S; Caro V; Cuervo N; Korotkova E; Combiescu M; Persu A; Aubert-Combiescu A; Delpeyroux F; Crainic R
J Virol; 2000 Sep; 74(18):8434-43. PubMed ID: 10954543
[TBL] [Abstract][Full Text] [Related]
16. A recombinant virus between the Sabin 1 and Sabin 3 vaccine strains of poliovirus as a possible candidate for a new type 3 poliovirus live vaccine strain.
Kohara M; Abe S; Komatsu T; Tago K; Arita M; Nomoto A
J Virol; 1988 Aug; 62(8):2828-35. PubMed ID: 2839704
[TBL] [Abstract][Full Text] [Related]
17. Growth kinetic analysis of bi-recombinant poliovirus vaccine strains.
Pliaka V; Dedepsidis E; Kyriakopoulou Z; Papadi G; Tsakogiannis D; Pratti A; Levidiotou-Stefanou S; Markoulatos P
Virus Genes; 2010 Apr; 40(2):200-11. PubMed ID: 20091423
[TBL] [Abstract][Full Text] [Related]
18. High diversity of poliovirus strains isolated from the central nervous system from patients with vaccine-associated paralytic poliomyelitis.
Georgescu MM; Delpeyroux F; Tardy-Panit M; Balanant J; Combiescu M; Combiescu AA; Guillot S; Crainic R
J Virol; 1994 Dec; 68(12):8089-101. PubMed ID: 7966599
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a rare natural intertypic type 2/type 3 penta-recombinant vaccine-derived poliovirus isolated from a child with acute flaccid paralysis.
Zhang Y; Wang H; Zhu S; Li Y; Song L; Liu Y; Liu G; Nishimura Y; Chen L; Yan D; Wang D; An H; Shimizu H; Xu A; Xu W
J Gen Virol; 2010 Feb; 91(Pt 2):421-9. PubMed ID: 19846676
[TBL] [Abstract][Full Text] [Related]
20. Genetic basis of attenuation of the Sabin type 2 vaccine strain of poliovirus in primates.
Macadam AJ; Pollard SR; Ferguson G; Skuce R; Wood D; Almond JW; Minor PD
Virology; 1993 Jan; 192(1):18-26. PubMed ID: 8390752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
